It is estimated that each year, 2,000 new cases of Mesothelioma are reported. The patients suffering from this cancerous disease have had prior exposure to asbestos, which is considered to be the only known cause of Mesothelioma. Mesotheliomic patients are often told of the short survival duration of 6 – 12 months. But doctors specialized in treating malignant Mesothelioma at leading cancer centers expect better survival rates. Though Mesothelioma causes immense pain and suffering to the victim along with short life expectancy, certain treatments have resulted in the successful reduction and removal of the cancerous tumors of Mesothelioma. Radiation Or Rado Therapy is one of the Mesothelioma treatments available to patients suffering from the asbestos-related cancer (Mesothelioma).

Treatment of MM using conventional therapies has not proved successful and patients have a median survival time of 6 - 12 months after presentation. The clinical behaviour of the malignancy is affected by several factors including the continuous mesothelial surface of the pleural cavity which favours local metastasis via exfoliated cells, invasion to underlying tissue and other organs within the pleural cavity, and the extremely long latency period between asbestos exposure and development of the disease.